Related Experiment Video
Updated: Nov 10, 2025

An Experimental Model of Myocardial Infarction for Studying Cardiac Repair and Remodeling in Knockout Mice
Published on: July 14, 2023
Galectin-3 in Predicting Mortality of Heart Failure: A Systematic Review and Meta-Analysis
Chenxia Wu1,2, Zhengtian Lv1,2, Xinyi Li1,2
1Department of Cardiology, The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, China.
Insights
Elevated galectin-3 levels predict increased mortality in both acute and chronic heart failure patients. This inflammatory marker is crucial for assessing heart failure prognosis.
Area of Science:
- Cardiology
- Biomarkers
- Clinical Research
Background:
- Galectin-3 is an inflammatory marker linked to cardiac fibrosis and heart failure.
- Understanding galectin-3's role in heart failure prognosis is critical.
Purpose of the Study:
- To systematically review and meta-analyze the predictive value of galectin-3 for mortality in heart failure patients.
Main Methods:
- Searched PubMed, Embase, and Cochrane Library for relevant studies.
- Included 19 studies with 9217 patients in the meta-analysis.
Main Results:
- Galectin-3 hazard ratio for mortality in chronic heart failure: 1.13 (95% CI: 1.07-1.21).
- Galectin-3 hazard ratio for mortality in acute heart failure: 2.17 (95% CI: 1.27-3.08).
Conclusions:
- Elevated galectin-3 levels are associated with higher mortality in both acute and chronic heart failure.
- Galectin-3 is a significant predictor of mortality in heart failure.
Background:
In recent years, galectin-3, an inflammatory marker, has been demonstrated to be closely related to cardiac fibrosis and heart failure. The purpose of this systematic review and meta-analysis is to define galectin-3 in predicting mortality of heart failure.
Methods:
PubMed, Embase, and the Cochrane Library were searched. A total of 1540 studies were identified, and of these studies, 19 involving 9217 patients were included in our meta-analysis.
Results:
The diagnostic hazard ratios of galectin-3 in predicting mortality in chronic heart failure patients was 1.13 (95% CI,:1.07-1.21 ) and 2.17 (95% CI:1.27-3.08) in acute heart failure (HF) patients.
Conclusions:
Our meta-analysis shows that elevated levels of galectin-3 are associated with higher mortality in both acute and chronic heart failure patients.
More Related Videos
Related Concept Videos
Heart Failure III: Clinical Manifestations
Heart Failure II: Pathophysiology
Heart Failure IV: Classification and Diagnostic Evaluation
Acute Coronary Syndrome III: Diagnostic Studies
Heart Failure I: Introduction
Pathophysiology of Heart Failure

